StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / combotopetherapeutics.com

Combotope Therapeutics

Combotope Therapeutics (combotopetherapeutics.com): 2 changes recorded in its website history since October 2023. Homepage last checked 5 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeTruly Tumor-Specific antibodies
    AfterAll Cancers - One Solution

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. HeadlineBetween and
    BeforeEGFR, VEGFR, HER2, CD37, FLT3, FGFR, CD19, CD22, CD27, CD25, CD30, CD33, CD38, CD43, Mesothelin, PD-L1, CD44, Podocalyxin (TRA1.60/80), C…
    AfterTruly Tumor-Specific antibodies

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 7 October 2023

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

EGFR, VEGFR, HER2, CD37, FLT3, FGFR, CD19, CD22, CD27, CD25, CD30, CD33, CD38, CD43, Mesothelin, PD-L1, CD44, Podocalyxin (TRA1.60/80), CD133, CD90, CD326, Cripto-1, ABCG2, CD24, CD49, Notch2, CD146 (

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. March 2026 – November 2026 · 3 captures · latest observed messagingAll Cancers - One Solution

    This wording observed 5 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 3 captures in this group
    • 10 March 2026 · All Cancers - One Solution archived page
    • 2 April 2026 · All Cancers - One Solution archived page
    • 5 November 2026 · All Cancers - One Solution current websiteHistorical capture not publicly available
  2. February 2025 – March 2025 · 2 capturesTruly Tumor-Specific antibodies

    This wording observed 31 March 2025.

    archived page
    Inspect 2 captures in this group
  3. October 2023 – September 2024 · 3 capturesEGFR, VEGFR, HER2, CD37, FLT3, FGFR, CD19, CD22, CD27, CD25, CD30, CD33, CD38, CD43, Mesothelin, PD-L1, CD44, Podocalyxin (TRA1.60/80), CD133, CD90, CD326, Cripto-1, ABCG2, CD24, CD49, Notch2, CD146 (

    This wording observed 5 September 2024.

    archived page
    Inspect 3 captures in this group
    • 7 October 2023 · EGFR, VEGFR, HER2, CD37, FLT3, FGFR, CD19, CD22, CD27, CD25, CD30, CD33, CD38, CD43, Mesothelin, PD-L1, CD44, Podocalyxin (TRA1.60/80), CD133, CD90, CD326, Cripto-1, ABCG2, CD24, CD49, Notch2, CD146 ( archived page
    • 12 June 2024 · EGFR, VEGFR, HER2, CD37, FLT3, FGFR, CD19, CD22, CD27, CD25, CD30, CD33, CD38, CD43, Mesothelin, PD-L1, CD44, Podocalyxin (TRA1.60/80), CD133, CD90, CD326, Cripto-1, ABCG2, CD24, CD49, Notch2, CD146 ( archived page
    • 5 September 2024 · EGFR, VEGFR, HER2, CD37, FLT3, FGFR, CD19, CD22, CD27, CD25, CD30, CD33, CD38, CD43, Mesothelin, PD-L1, CD44, Podocalyxin (TRA1.60/80), CD133, CD90, CD326, Cripto-1, ABCG2, CD24, CD49, Notch2, CD146 ( archived page

Cite this record

StartupHistory, “Combotope Therapeutics” company record, https://startuphistory.org/c/combotopetherapeutics.com

Machine-readable: /c/combotopetherapeutics.com.json. How changes are found: method.